Credit: Technology Networks.

Andrew Heron, PhD profile page

Chief Executive Officer

at Portal Biotech

Dr. Andrew Heron is the CEO at Portal Biotech. As CEO and co-founder of Portal Biotech, Heron leads a team building the world’s first platform for full-length, single-molecule protein sequencing. He is reimagining proteomics and metabolomics by building a versatile and accessible benchtop platform for comprehensive characterization of proteins and metabolites.

Got a Question for Andrew Heron, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.

Content Written By, Reviewed By, or Featuring Andrew Heron, PhD

Total: 1

Mass spectrometry instrument analyzing samples in laboratory, illustrating mass spec technology.

Industry Insight

How Proteomics Startups Are Overcoming Scale and Precision Challenges

Industry experts highlight advances in proteomics workflows that overcome trade-offs between resolution and throughput. Innovations include standardized quantification, nanopore protein sequencing, and spatial omics platforms.